MGMT promoter (MGMTp) methylation downregulates the protein synthesis of the MGMT protein and, by proxy, DNA repair, which enables alkylating agents to exert more damage to the malignant glioma cells [9,26,27]. This evidence concerns the gene MGMT and central nervous system cancer.